The nocebo effect: the dark side of placebos

反安慰剂效应：安慰剂的阴暗面

• 批准号: DP180102061
• 负责人: Prof Ben Colagiuri
• 金额: $ 23.73万
• 依托单位: The University of Sydney
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP180102061
• 关键词: nocebo; effect; dark; side; placebos

This project aims to understand the nocebo effect - when negative information triggers adverse outcomes - and how to reduce it. Despite a wealth of evidence for the existence of nocebo effects across various settings, there are critical gaps in our current understanding of how these effects occur and whether we can reduce them. To address this, the current project develops and experimentally tests a new model of the nocebo effect that will uncover its underlying mechanisms as well as strategies to inhibit it. The expected outcomes from this project can contribute to minimising the substantial individual and societal harm caused by the nocebo effect and associated health and economic costs.

该项目旨在了解反安慰剂效应-当负面信息引发不良后果时-以及如何减少它。尽管有大量证据表明反安慰剂效应在各种环境中存在，但我们目前对这些效应如何发生以及我们是否可以减少它们的理解存在重大差距。为了解决这个问题，目前的项目开发和实验测试反安慰剂效应的新模型，将揭示其潜在的机制以及抑制它的策略。该项目的预期成果可以有助于最大限度地减少反安慰剂效应造成的重大个人和社会危害以及相关的健康和经济成本。